Register entry

Nissui Corporation

Data as of · How to read this entry

Registered sites
2
Active NDC listings
2
Live patents
0
Countries
1
Base
Japan
Authorisation

Registered operations

Active ingredient (API) manufacture2
Sites

Registered establishments

2
EstablishmentAddressRegistered forFEI / DUNS
Nissui Corporation18-2, HIGASHIFUKASHIBA, KAMISU, IBARAKI 314-0103, Japan (JPN)Active ingredient (API) manufacture3009589537715315693
Nissui Corporation7, OKUBO, TSUKUBA, IBARAKI 300-2611, Japan (JPN)Active ingredient (API) manufacture3004317885706198215
Catalogue

Drug listings by form and route

2

2 active NDC listings: 2 drug for further processing. By marketing category: DRUG FOR FURTHER PROCESSING 2.

Dosage formNDCs
liquid2
RouteNDCs
Labeller name on the listingNDCs
nissui corporation2
Catalogue

Marketed products

2
BrandGeneric nameForm / routeNDC
-Icosapent Ethylliquid71215-101DRUG FOR FURTHER PROCESSING
-Icosapent Ethylliquid71215-102DRUG FOR FURTHER PROCESSING
Neighbours

Registered in the same town

1
Compare

Comparable companies in Japan

Enquiry

Common questions

Is Nissui Corporation FDA approved?
Nissui Corporation holds 2 FDA-registered establishments in Japan. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
Where are Nissui Corporation's drugs manufactured?
The FDA register lists KAMISU; TSUKUBA. Registered operations: active ingredient (API) manufacture.
What drugs does Nissui Corporation make?
2 products are listed under Nissui Corporation in the openFDA NDC Directory, most often as liquid. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.